Center for Translational Pediatric Research (CTPR): Enhancing SARS-CoV-2 Sequencing Efforts for Variants in the State of Arkansas
Center for Translational Pediatric Research (CTPR): Enhancing SARS-CoV-2 Sequencing Efforts for Variants in the State of Arkansas
批准号:
10595406
负责人:
Alan Tackett
金额:
$77.0万
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
未结题
起止时间:
2017-07-11 至 2027-06-30
关键词:
2019-nCoVArkansasAwardBioinformaticsBiomedical ResearchCell NucleusCenters of Research ExcellenceChildChildhoodData AnalysesDevelopment PlansDiseaseExtramural ActivitiesFoundationsFundingGenomicsGoalsGrantHuman ResourcesIndividualInstitutionLeadershipMalignant NeoplasmsMentorsMissionNational Institute of General Medical SciencesPediatric ResearchPhasePilot ProjectsPopulationProgram DevelopmentProteomicsResearchResearch InfrastructureResearch InstituteResearch PersonnelResearch Project GrantsResearch SupportResourcesRoleStructureSupport SystemSystems BiologyTeacher Professional DevelopmentVariantcareerdata integrationdisease mechanisms studyepigenomicsexperiencefaculty mentormembermid-career facultymultidisciplinaryprofessorprogramsproteogenomicsrecruitsenior facultyservice providerssuccesstenure tracktherapeutic target
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Summary
In July of 2017, we launched Phase I of the COBRE Center for Translational Pediatric Research at Arkansas
Children’s Research Institute in Little Rock, Arkansas. The mission of the center is to use proteogenomic
approaches to identify epigenomic mechanisms and therapeutic targets in diseases, including cancer, impacting
or translatable to the pediatric population. The unifying theme of research among center members is utilizing
systems biology approaches and sophisticated bioinformatics for studying disease mechanism. The goal of
Phase I was to establish the foundation of the center, expand the pool of successful investigators with a Faculty
Development Plan, and support systems-level core resources. Towards this goal, the center was created with a
nucleus of 4 Research Project Leaders and 2 research cores, Proteomics Core and Genomics & Bioinformatics
Core. Through use of a mentored Faculty Development Program overseen by the Administrative Core, the junior
investigators from Phase I received 9 RPG-level grants, including an U01-award. Additionally, we were able to
“graduate” both Phase I research cores to self-sustainability. Collectively, during the past 4 years of Phase I, we
have made substantial progress towards establishing a multi-disciplinary, thematic research center through
expansion of our center members, transitioning core resources to independence, and extramural funding –
demonstrating how the center is moving in the direction of long-term sustainability beyond COBRE support.
Building on the momentum of Phase I, our goals in Phase II are to further enhance our institutional research
infrastructure by developing our multi-disciplinary, thematic research center through strategic expansion of the
critical mass of investigators, investing into research infrastructure, and implementing a plan for long-term center
sustainability beyond COBRE support. We will provide structured mentoring and support to an initial group of 5
Research Project Leaders in Phase II. Furthermore, we will expand the pool of investigators in the center through
institutional commitments to recruit 4 Assistant and 1 Associate or Full Professor to the center. To support needs
of the expanding critical mass of investigators, we will develop a new Proteogenomics Core that is essential for
the evolving research mission of the center. This unique core will provide Research Project Leaders and other
center members access to experienced personnel for non-standard proteomic, genomic, and epigenomic
applications, and access to highly skilled bioinformaticians for cutting-edge data analysis and integration. To
support the expansion of investigators and a new research core, the Administrative Core will provide a Faculty
Development Plan, Pilot Project Program, operational oversight, and leadership as the center prepares to
transition to long-term sustainability. Upon completion of Phase II, we anticipate having a critical mass of junior,
mid-career, and senior investigators in the center who have access to world-class systems biology cores, which
will enable center members to successfully compete for individual, multi-investigator, and program-level grants
to support transition of the center to long-term sustainability beyond COBRE support.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Identification of Druggable Targets to Complement Melanoma Therapy
-
批准号:10163815
-
项目类别:
-
资助金额:$34.79万
-
财政年份:2019
-
负责人:Alan Tackett
-
依托单位:
Identification of Druggable Targets to Complement Melanoma Therapy
-
批准号:10630160
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2019
-
负责人:Alan Tackett
-
依托单位:
Identification of Druggable Targets to Complement Melanoma Therapy
-
批准号:10412077
-
项目类别:
-
资助金额:$34.1万
-
财政年份:2019
-
负责人:Alan Tackett
-
依托单位:
Center for Translational Pediatric Research
-
批准号:10854464
-
项目类别:
-
资助金额:$95.57万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Administrative Core
-
批准号:9983121
-
项目类别:
-
资助金额:$72.6万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Administrative Core
-
批准号:10669470
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Administrative Core
-
批准号:10885884
-
项目类别:
-
资助金额:$95.57万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Administrative Core
-
批准号:10669289
-
项目类别:
-
资助金额:$60.69万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Center for Translational Pediatric Research (CTPR)
-
批准号:10380963
-
项目类别:
-
资助金额:$77.0万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Center for Translational Pediatric Research
-
批准号:10669288
-
项目类别:
-
资助金额:$230.3万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Center for Translational Pediatric Research (CTPR)
-
批准号:9983103
-
项目类别:
-
资助金额:$227.12万
-
财政年份:2017
-
负责人:Alan Tackett
-
依托单位:
Technology for Identification of Epiproteomes in Tissue Samples
-
批准号:9128152
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2016
-
负责人:Alan Tackett
-
依托单位:
Identifying the Epigenetic Regulation of Arsenic Exposure
-
批准号:9050678
-
项目类别:
-
资助金额:$18.63万
-
财政年份:2015
-
负责人:Alan Tackett
-
依托单位:
Identifying the Epigenetic Regulation of Arsenic Exposure
-
批准号:8869954
-
项目类别:
-
资助金额:$22.35万
-
财政年份:2015
-
负责人:Alan Tackett
-
依托单位:
Identifying the epigenetic regulation of arsenic exposure - Revision 2
-
批准号:9274775
-
项目类别:
-
资助金额:$7.72万
-
财政年份:2015
-
负责人:Alan Tackett
-
依托单位:
Using ChAP-MS to Study Macromolecular Chromatin Composition during Transcription
-
批准号:8489555
-
项目类别:
-
资助金额:$30.92万
-
财政年份:2013
-
负责人:Alan Tackett
-
依托单位:
Development of MassSQUIRM to Quantitatively Measure Lysine Methylation
-
批准号:8529942
-
项目类别:
-
资助金额:$14.47万
-
财政年份:2013
-
负责人:Alan Tackett
-
依托单位:
Using ChAP-MS to Study Macromolecular Chromatin Composition during Transcription
-
批准号:9058085
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2013
-
负责人:Alan Tackett
-
依托单位:
Development of MassSQUIRM to Quantitatively Measure Lysine Methylation
-
批准号:8723135
-
项目类别:
-
资助金额:$14.04万
-
财政年份:2013
-
负责人:Alan Tackett
-
依托单位:
Using ChAP-MS to Study Macromolecular Chromatin Composition during Transcription
-
批准号:8840612
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2013
-
负责人:Alan Tackett
-
依托单位:
海外基金